Jpmorgan Chase & CO Global X Fds Genomics & Biotec Transaction History

Jpmorgan Chase & CO

  • $1.1 Trillion
  • Q1 2024

A detailed history of Jpmorgan Chase & CO transactions in Global X Fds Genomics & Biotec stock. As of the latest transaction made, Jpmorgan Chase & CO holds 250 shares of GNOM stock, worth $2,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 0 Infinity%
Holding current value
$2,600
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$10.75 - $12.29 $2,687 - $3,072
250 New
250 $2,000
Q4 2023

Feb 12, 2024
SELL
$8.77 - $11.77 $3,885 - $5,214
-443 Closed
0 $0
Q3 2023

Nov 14, 2023
BUY
$10.07 - $12.5 $4,461 - $5,537
443 New
443 $4,000
Q2 2023

Aug 11, 2023
BUY
$11.99 - $13.07 $0 - $0
0 New
0 $0
Q1 2023

May 18, 2023
BUY
$11.73 - $14.18 $0 - $0
0 New
0 $0
Q1 2023

May 11, 2023
BUY
$11.73 - $14.18 $0 - $0
0 New
0 $0
Q4 2022

Feb 13, 2023
BUY
$12.11 - $13.81 $0 - $0
0 New
0 $0

Others Institutions Holding GNOM

# of Institutions
68
Shares Held
2.72M
Call Options Held
200
Put Options Held
500
View Full List

About GLOBAL X FDS GENOMICS & BIOTEC

GNOM Quotes by TradingView
  • Ticker GNOM
  • Sector ETFs
  • Industry ETFs
More about GNOM
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email